Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPines, A.en
dc.contributor.authorSturdee, D.en
dc.contributor.authorMacLennan, A.en
dc.identifier.citationClimacteric, 2012; 15(3):213-216en
dc.description.abstractThe quality of life of countless menopausal women world-wide has been signifi cantly diminished following the sensationalist reporting of the Women’s Health Initiative (WHI) and the resulting 50% or more decline in the use of hormone replacement therapy (HRT) over the subsequent 10 years. Quality of life is difficult to measure as there are so many contributing factors and a large number of different instruments, some of which assess general health and only a few which specifi cally include symptoms related to menopause. HRT improves quality of life of symptomatic menopausal women and some studies of the effects of HRT provide reliable evidence on quality of life other than reduction in vasomotor symptoms. Until there is a better understanding of the minimal risks of HRT for the majority of women, too many will continue to suffer a reduced quality of life unnecessarily.en
dc.description.statementofresponsibilityA. Pines, D.W. Sturdee and A.H. MacLennanen
dc.publisherParthenon Publishing Groupen
dc.rights© 2012 International Menopause Societyen
dc.subjectQuality of life; Women's Health Initiative; stopping HRTen
dc.titleQuality of life and the role of menopausal hormone therapyen
dc.typeJournal articleen
pubs.library.collectionObstetrics and Gynaecology publicationsen
Appears in Collections:Obstetrics and Gynaecology publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.